Global Business Expansion of Collagen Peptides

「As a result, total collagen peptide sales amounted to ¥7,265 million, up 12.0% year on year.」

「(Collagen peptides) In Japan, sales declined due to lower sales of customers' collagen products and other factors. In North America, sales remained strong on continued robust demand, including demand for protein bars. Demand also remained solid in India and Asia. As a result, total collagen peptide sales amounted to ¥3,309 million, down 2.1% year on year.」

「In North America, sales volumes expanded through new sales expansion and other efforts despite continued lower selling prices due to price competition, and sales increased. Demand also remained strong in India and Asia. As a result, total collagen peptide sales amounted to ¥6,489 million, up 4.2% year on year.」

「In North America, sales increased as sales volumes expanded through new sales expansion and other efforts, despite a decline in selling prices due to price competition amid recovering market conditions. Sales also increased in India, mainly due to strong exports. As a result, collagen peptide sales amounted to ¥3,382 million, up 15.9% year on year.」

「In Health Support, total sales increased due to growth in gelatin-for-capsule sales and price revisions. In Japan, sales of beauty-use collagen peptides fell below the previous year due to sluggish sales of customers' collagen products, but sales of gelatin for capsules increased. Overseas, in North America, sales of gelatin for capsules remained solid, but collagen peptide demand was softening due to inflation and sales declined. In Asia, collagen peptide sales declined due to inflation and intensifying price competition. In India, sales of gelatin for capsules remained solid, and sales increased. As a result, total Health Support sales amounted to ¥14,919 million, up 7.0% year on year.」

「Overseas, in North America, demand for collagen peptides was softening due to inflation, but sales increased as sales of gelatin for capsules remained solid. In Asia, collagen peptide sales declined due to inflation and intensifying price competition. In India, sales of gelatin for capsules remained solid, and sales increased. As a result, total Health Support sales amounted to ¥9,436 million, up 3.7% year on year.」

「In Health Support, total sales increased due to solid demand for gelatin for capsules and collagen peptides, as well as price revisions to appropriate levels. In Japan, sales of beauty-use collagen peptides increased on expectations of a recovery in inbound demand. Sales also increased in the direct sales business, which sells collagen health foods to general consumers by mail order, supported by proactive advertising using mass media. Overseas, market conditions were weak in North America and Asia due to inflation and other factors, and sales of beauty-use collagen peptides declined. In India, however, sales of gelatin for capsules used in supplements and pharmaceuticals remained solid. As a result, total Health Support sales amounted to ¥4,333 million, down 4.1% year on year.」

「In Health Support, the company worked to expand sales by rebranding collagen health foods for general consumers and strengthening advertising.」

「In Health Support, total sales increased as overseas sales of beauty-use collagen peptides grew. In Japan, sales of beauty-use collagen peptides were at the same level as in the same period of the previous year due to sluggish sales of customers' collagen products, while sales of gelatin for capsules increased on solid demand. In the direct sales business, which sells collagen health foods to general consumers by mail order, sales increased as strengthened advertising translated into results. Overseas, collagen peptide sales were strong in North America due to robust demand. In Asia, sales of beauty-use collagen peptides promoted for their functionality remained solid. In addition, sales of gelatin for capsules increased in North America and India as health promotion and disease-prevention awareness rose during the COVID-19 pandemic. As a result, total Health Support sales amounted to ¥9,098 million, up 27.9% year on year.」

「Overseas, sales increased due to strong demand for collagen peptides in North America, strong sales of beauty-use collagen peptides promoted for their functionality in Asia, and strong demand in North America and India for gelatin for capsules amid heightened health promotion and disease-prevention awareness during the COVID-19 pandemic. As a result, total Health Support sales amounted to ¥4,517 million, up 22.9% year on year.」

「Overseas, sales of beauty-use collagen peptide products in North America were at the same level as in the same period of the previous year, while sales of beauty-use collagen peptides promoted for their functionality were strong in Asia and sales increased. Demand for gelatin for capsules remained strong due to heightened health promotion and disease-prevention awareness during the COVID-19 pandemic, but sales declined because of disruptions in ocean container shipping. In India, sales increased as sales for capsules used in pharmaceuticals and health foods remained solid and collagen peptide sales expanded.」

「In Health Support, exports of gelatin for capsules declined due to disruptions in ocean container shipping, but total sales increased as sales of beauty-use collagen peptides grew in Japan and overseas. In Japan, sales of beauty-use collagen peptides and gelatin for capsules increased as in-store sales recovered and customers' new collagen products continued to sell well. Overseas, collagen peptide sales increased in North America as demand recovered for beauty-use products. In Asia, demand for beauty-use collagen peptides promoted for their functionality remained solid, and sales increased. In India, sales increased as sales for capsules used in pharmaceuticals and health foods remained solid and collagen peptide sales also increased. As a result, total Health Support sales amounted to ¥7,115 million, up 4.6% year on year.」

「Overseas, collagen peptide sales increased in North America as demand recovered for beauty-use products and new sales expansion of high-functionality collagen peptides contributed to growth. In Asia, sales increased for beauty-use collagen peptides promoted for their functionality.」

「In April 2021, the company absorbed and merged Nitta Biolab Co., Ltd., its subsidiary engaged in direct-to-consumer sales, and launched a direct sales team. Going forward, it aims to strengthen product development further and improve sales efficiency. In addition to focusing on sales of its first food with function claims, Wellnex 肌。 (Hadamaru), the company will expand its direct sales business through rebranding existing products and strengthening marketing.」

「In Japan, sales for beauty supplement applications declined due to lower in-store sales at drugstores and other outlets resulting from the spread of COVID-19, as well as the disappearance of inbound demand. Overseas, collagen peptide sales declined in North America due to the slowdown in market growth and the impact of COVID-19. Meanwhile, sales of gelatin for soft capsules increased on solid demand for capsules used in health foods. In Asia, sales increased due to solid sales of halal-compliant products for capsule applications and expanded sales activities promoting the functionality of collagen peptides for beauty applications. In India, sales declined slightly year on year due to lower sales for capsules used in pharmaceuticals and health foods. As a result, total Health Support sales amounted to ¥6,805 million, down 8.1% year on year.」

「In Japan, sales declined for beauty supplement applications. Overseas, in North America, collagen peptide sales declined due to oversupply of collagen peptides and lower sales of beauty supplements. Sales of gelatin for capsules used in health foods, however, remained at the previous year's level. In Asia, sales increased due to higher sales of halal-compliant products for capsule applications and expanded sales activities promoting the functionality of collagen peptides for beauty applications. In India, demand for capsules for pharmaceutical and health food applications remained solid.」

「In Japan, demand from major customers remained solid in the beauty supplement segment, and sales of collagen peptide products increased. Overseas, sales increased in North America as the collagen peptide market for health and beauty applications expanded. Sales of gelatin and collagen peptide products also increased as sales for capsule applications in health foods remained solid. In Asia, sales increased as the company actively expanded sales of collagen peptides, while in India sales for capsule applications in pharmaceuticals and health foods remained solid.」

「In Japan, sales of collagen peptide products increased as sales of renewed products from major customers remained solid in the beauty supplement segment. Overseas, in North America, the collagen peptide market for beauty applications expanded, while sales for capsule applications in health foods also remained solid. In India, sales increased as capsule applications for pharmaceuticals and health foods remained solid.」

「Overseas, sales increased in North America as the collagen supplement market expanded, and sales to the capsule market for health foods remained solid. In India, demand for capsules for pharmaceutical and health food applications remained solid, and sales increased. In China, the collagen peptide market for health and beauty applications, which had continued to expand, entered an adjustment phase, but sales increased due to a focus on exports.」

「Overseas, sales for capsule applications in North America remained solid as market conditions recovered, while sales increased for beauty applications due to expanded sales of collagen peptides produced at the North American plant. Sales for capsule applications in Asia declined, affected by lower sales resulting from flooding in southern India in August of the previous year.」

「In Japan, demand for capsules used in health foods remained solid, driven by growing health consciousness and an increase in the number of drugstores, and sales increased. Sales of collagen peptides for beauty applications, however, declined. Overseas, sales for capsule applications in North America remained solid as market conditions recovered. Sales for capsule applications in Asia declined, partly due to flooding in southern India.」

「In Japan, overall sales declined because sales to major customers fell below the previous year and sales to Asia decreased. Profit increased due to lower manufacturing costs, including cost reductions.」

「In Japan, the functionality of collagen peptides has become widely recognized, sales in the supplement market remained solid, and sales of the company's own products for general consumers also increased. In China, demand for beauty supplements expanded, and sales remained strong.」

「In Japan, awareness of the functionality of collagen peptides continued to improve, and sales in the supplement market remained solid. In China, previous sales promotion activities and other efforts translated into results, and sales remained strong.」

「Sales of collagen peptides were solid in the supplement market as awareness of their functionality increased.」

「Sales of collagen peptides increased as awareness grew, contributing to a recovery in earnings.」

「The company will work to expand sales to the general food market and improve consumer awareness of the product's functionality. It will also actively pursue the exploration and development of new functionalities, including verification of effects on brain function, and develop new, highly profitable markets.」

「Sales of collagen peptides to the health food market declined due to lower inbound demand, but sales to the general food market are beginning to offset the decline.」

「The objective is to expand sales and increase market share in North America for gelatin and collagen peptides by incorporating the customers and products handled by (former) Vyse Gelatin in North America.」

「Sales of collagen peptides to the health food market declined, partly because inbound demand had settled down.」

「In addition to meeting this increase in demand, the company will develop new, highly profitable markets by launching products with enhanced functionality. It will also expand its business globally in the US, Chinese, and Asian markets by leveraging each manufacturing facility.」